Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $570.8500 (-1.5%) ($567.0600 - $584.5935) on Mon. Nov. 23, 2015. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.82% (three month average) | RSI | 46 | Latest Price | $570.8500(-1.5%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 0.4% a day on average for past five trading days. | Weekly Trend | REGN advances 1.3% a week on average for past two weeks. | Market Behavior | Normal for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(64%) XLV(51%) XBI(49%) QQQ(42%) IVW(41%) | Factors Impacting REGN price | REGN will decline at least -1.41% in a week (0% probabilities). VIXM(-14%) TLT(-9%) UUP(-6%) SHY(-4%) TIP(-3%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.41% (StdDev 2.82%) | Hourly BBV | 0 () | Intraday Trend | -0.9% | | | |
|
5 Day Moving Average | $577.95(-1.23%) | 10 Day Moving Average | $568.54(0.41%) | 20 Day Moving Average | $567.28(0.63%) | To recent high | -2.8% | To recent low | 26.3% | Market Cap | $60.526b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |